MeSH term
Frequency | Condition_Probility | Female | 115 | 0.0 |
Humans | 246 | 0.0 |
Mutation | 6 | 0.0 |
Adult | 98 | 0.0 |
Algorithms | 3 | 0.0 |
Area Under Curve | 3 | 0.0 |
Chromatography, High Pressure Liquid | 6 | 0.0 |
Comparative Study | 59 | 0.0 |
Cross-Over Studies | 3 | 0.0 |
Double-Blind Method | 2 | 0.0 |
Male | 116 | 0.0 |
Reproducibility of Results | 7 | 0.0 |
Research Support, Non-U.S. Gov't | 125 | 0.0 |
Solubility | 4 | 0.0 |
Tablets | 4 | 11.0 |
Adolescent | 23 | 0.0 |
Auditory Threshold/*physiology | 3 | 60.0 |
Child | 9 | 0.0 |
Linear Models | 4 | 0.0 |
Otoacoustic Emissions, Spontaneous/*physiology | 33 | 100.0 |
Pitch Perception/*physiology | 8 | 72.0 |
Predictive Value of Tests | 4 | 0.0 |
Reference Values | 13 | 0.0 |
Acoustic Stimulation | 22 | 25.0 |
Auditory Threshold/physiology | 13 | 68.0 |
Basilar Membrane/*physiopathology | 2 | 100.0 |
Fourier Analysis | 5 | 8.0 |
Hearing Loss, Sensorineural/diagnosis/*physiopathology | 2 | 100.0 |
Research Support, U.S. Gov't, P.H.S. | 62 | 0.0 |
Sound Spectrography | 8 | 72.0 |
Animals | 75 | 0.0 |
Bone Density/*genetics | 2 | 1.0 |
Chromosome Mapping | 9 | 0.0 |
Crosses, Genetic | 11 | 1.0 |
Epistasis, Genetic | 2 | 3.0 |
Genetic Markers | 2 | 0.0 |
Lod Score | 4 | 0.0 |
Mice | 31 | 0.0 |
Mice, Inbred Strains | 9 | 1.0 |
Phenotype | 9 | 0.0 |
*Quantitative Trait, Heritable | 3 | 6.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 13 | 0.0 |
Aged | 17 | 0.0 |
Cholesterol/*blood | 2 | 0.0 |
F2-Isoprostanes/*blood | 2 | 100.0 |
Mass Fragmentography | 2 | 0.0 |
Middle Aged | 42 | 0.0 |
Cochlea/*physiology | 37 | 90.0 |
Acoustic Impedance Tests | 2 | 33.0 |
Audiometry, Pure-Tone | 8 | 20.0 |
Child, Preschool | 4 | 0.0 |
Cochlea/physiology | 6 | 75.0 |
Hearing Disorders/diagnosis/*epidemiology | 2 | 50.0 |
Laterality/*physiology | 2 | 6.0 |
Sex Factors | 4 | 0.0 |
Guinea Pigs | 4 | 0.0 |
Hearing/*physiology | 11 | 61.0 |
*Models, Biological | 6 | 3.0 |
Biological Availability | 3 | 1.0 |
*Oxidative Stress | 3 | 1.0 |
Alleles | 2 | 0.0 |
Base Sequence | 17 | 0.0 |
Factor V/*genetics | 2 | 1.0 |
Genetic Predisposition to Disease | 2 | 0.0 |
Genotype | 8 | 0.0 |
Molecular Sequence Data | 24 | 0.0 |
Prothrombin/*genetics | 8 | 12.0 |
Risk Factors | 4 | 0.0 |
Variation (Genetics) | 2 | 0.0 |
Body Weight | 3 | 0.0 |
Mice, Inbred C57BL | 10 | 0.0 |
Mice, Inbred DBA | 3 | 0.0 |
Quantitative Trait, Heritable | 4 | 7.0 |
Sex Characteristics | 2 | 0.0 |
Analysis of Variance | 7 | 0.0 |
Noise | 10 | 62.0 |
*Chromosome Mapping | 4 | 0.0 |
English Abstract | 30 | 0.0 |
Mice, Transgenic | 4 | 0.0 |
Aging/*physiology | 2 | 0.0 |
Otoacoustic Emissions, Spontaneous | 3 | 42.0 |
*Perceptual Distortion | 7 | 100.0 |
*Otoacoustic Emissions, Spontaneous | 7 | 87.0 |
Time Factors | 13 | 0.0 |
DNA Primers | 6 | 0.0 |
Polymerase Chain Reaction | 7 | 0.0 |
RNA, Messenger/*genetics | 2 | 0.0 |
Sodium-Potassium-Chloride Symporters | 2 | 15.0 |
DNA Primers/genetics | 3 | 0.0 |
Disease Models, Animal | 3 | 0.0 |
Hybridization, Genetic | 3 | 4.0 |
Microsatellite Repeats | 3 | 0.0 |
Hela Cells | 3 | 0.0 |
Immunoblotting | 4 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Transfection | 3 | 0.0 |
Ear Canal/physiology | 2 | 100.0 |
Psychophysics | 2 | 7.0 |
Cells, Cultured | 5 | 0.0 |
In Vitro | 8 | 0.0 |
Rats | 12 | 0.0 |
Rats, Wistar | 2 | 0.0 |
Surface Properties | 2 | 1.0 |
Logistic Models | 2 | 0.0 |
Prospective Studies | 3 | 0.0 |
ROC Curve | 2 | 1.0 |
Sensitivity and Specificity | 9 | 0.0 |
Chemistry, Pharmaceutical | 2 | 5.0 |
Infant, Newborn | 10 | 0.0 |
*Neonatal Screening | 2 | 8.0 |
Photic Stimulation/methods | 2 | 8.0 |
Cattle | 7 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 5 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Cell Line | 8 | 0.0 |
Age Factors | 7 | 0.0 |
Biomechanics | 2 | 1.0 |
Cochlea/physiopathology | 4 | 80.0 |
Severity of Illness Index | 2 | 0.0 |
Models, Theoretical | 4 | 3.0 |
Audiometry | 5 | 11.0 |
*Speech Acoustics | 2 | 25.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 3 | 0.0 |
Audiometry, Pure-Tone/methods | 3 | 60.0 |
Rabbits | 5 | 0.0 |
*Hearing | 4 | 57.0 |
Multivariate Analysis | 3 | 0.0 |
Perceptual Distortion | 2 | 66.0 |
Reaction Time/physiology | 2 | 2.0 |
Phylogeny | 2 | 0.0 |
Amino Acid Sequence | 15 | 0.0 |
Binding Sites | 2 | 0.0 |
Models, Molecular | 2 | 0.0 |
Auditory Perception/physiology | 3 | 42.0 |
Antibody Specificity | 3 | 0.0 |
Immunization | 2 | 0.0 |
Mites/*immunology | 3 | 6.0 |
Acoustic Stimulation/*methods | 2 | 50.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Species Specificity | 6 | 0.0 |
Cloning, Molecular | 8 | 0.0 |
Gene Expression | 2 | 0.0 |
Drug Combinations | 2 | 0.0 |
Hearing Loss, Sensorineural/*diagnosis | 3 | 100.0 |
Efferent Pathways/physiology | 3 | 50.0 |
Electric Stimulation | 2 | 0.0 |
Models, Biological | 9 | 0.0 |
Antineoplastic Agents/*pharmacology | 2 | 0.0 |
Gestational Age | 2 | 0.0 |
Infant, Premature | 2 | 1.0 |
*Noise | 4 | 40.0 |
Prognosis | 2 | 0.0 |
Serotonin Antagonists/pharmacology | 2 | 12.0 |
*Tomography, Emission-Computed | 3 | 6.0 |
Mice, Inbred BALB C | 6 | 0.0 |
*Acoustic Stimulation | 18 | 78.0 |
Centrifugation, Density Gradient | 2 | 0.0 |
Gels | 2 | 2.0 |
Glycosylation | 2 | 0.0 |
Immunohistochemistry | 4 | 0.0 |
Protein Conformation | 2 | 0.0 |
Electroencephalography | 2 | 0.0 |
Reaction Time | 2 | 1.0 |
DNA | 2 | 0.0 |
Diabetes Mellitus, Experimental/genetics | 2 | 66.0 |
Mice, Inbred C3H | 3 | 0.0 |
Auditory Perception/*physiology | 5 | 18.0 |
Auditory Threshold | 13 | 34.0 |
Cochlea/*physiopathology | 5 | 100.0 |
Differential Threshold | 2 | 18.0 |
Hearing Loss, Sensorineural/*physiopathology | 2 | 100.0 |
Chronic Disease | 2 | 0.0 |
Disease Progression | 2 | 0.0 |
Autoantibodies/*analysis | 2 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 6 | 0.0 |
Biological Transport | 2 | 0.0 |
Infant | 4 | 0.0 |
Pregnancy | 4 | 0.0 |
*Variation (Genetics) | 3 | 0.0 |
*Audiometry, Pure-Tone | 3 | 60.0 |
Hearing/physiology | 3 | 42.0 |
Indomethacin/pharmacology | 2 | 0.0 |
Prostaglandins/biosynthesis | 2 | 7.0 |
Antigens, Dermatophagoides | 5 | 9.0 |
Blotting, Western | 3 | 0.0 |
Glycoproteins/*immunology | 2 | 2.0 |
Radioallergosorbent Test | 3 | 6.0 |
Recombinant Proteins/immunology | 2 | 0.0 |
Tissue Distribution | 3 | 0.0 |
Cochlear Nerve/physiology | 2 | 100.0 |
Perceptual Distortion/physiology | 2 | 100.0 |
Pitch Perception/physiology | 2 | 66.0 |
Basilar Membrane/*physiology | 2 | 100.0 |
Chinchilla | 2 | 33.0 |
Loudness Perception/physiology | 2 | 100.0 |
Otoacoustic Emissions, Spontaneous/physiology | 2 | 100.0 |
Perceptual Distortion/*physiology | 4 | 80.0 |
Psychoacoustics | 7 | 46.0 |
Escherichia coli/genetics | 3 | 0.0 |
*Sound | 2 | 33.0 |
Antibodies, Monoclonal/*immunology | 2 | 0.0 |
Epitope Mapping | 2 | 0.0 |
Protein Binding | 4 | 0.0 |
Structure-Activity Relationship | 3 | 0.0 |
*Acoustics | 3 | 75.0 |
Kinetics | 6 | 0.0 |
Substrate Specificity | 2 | 0.0 |
Hearing Disorders/*diagnosis | 2 | 66.0 |
Hair Color/*genetics | 2 | 7.0 |
Linkage (Genetics) | 4 | 0.0 |
Cross Reactions | 2 | 0.0 |
Trypsin | 2 | 1.0 |
*Auditory Threshold | 2 | 66.0 |
Genetic Markers/*genetics | 4 | 3.0 |
Linkage (Genetics)/genetics | 2 | 0.0 |
Models, Genetic | 3 | 0.0 |
Ear, Middle/physiology | 3 | 60.0 |
Pedigree | 2 | 0.0 |
*Music | 2 | 50.0 |
Aged, 80 and over | 5 | 0.0 |
Anti-Inflammatory Agents, Non-Steroidal/*pharmacology | 2 | 1.0 |
Diterpenes/*pharmacology | 2 | 6.0 |
Reactive Oxygen Species/metabolism | 2 | 0.0 |
Genes, Structural | 2 | 0.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Evaluation Studies | 2 | 0.0 |
Plant Extracts/*pharmacology | 2 | 2.0 |
*Perceptual Masking | 4 | 80.0 |
*Phonetics | 2 | 14.0 |
Pitch Perception | 2 | 66.0 |
Signal Processing, Computer-Assisted | 2 | 4.0 |
*Speech Perception | 2 | 12.0 |
Laterality | 2 | 3.0 |
Temperature | 2 | 0.0 |
Retina/physiology | 2 | 15.0 |
*Cochlear Microphonic Potentials | 2 | 66.0 |
Loudness Perception/*physiology | 4 | 100.0 |
Noise/adverse effects | 2 | 33.0 |
Prostaglandins E/*blood | 2 | 22.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Hair Cells/physiology | 2 | 66.0 |
Isoelectric Focusing | 2 | 0.0 |
Swine | 3 | 0.0 |
*Polymorphism, Genetic | 2 | 0.0 |
*Polymorphism, Restriction Fragment Length | 5 | 0.0 |
Prostaglandins/*pharmacology | 3 | 12.0 |
Tetradecanoylphorbol Acetate/pharmacology | 2 | 0.0 |
Tumor Necrosis Factor-alpha/biosynthesis | 2 | 0.0 |
*Crosses, Genetic | 3 | 50.0 |
*Electroencephalography | 2 | 1.0 |
Epilepsy, Absence/*genetics | 2 | 11.0 |
Evoked Potentials/genetics | 2 | 100.0 |
Rats, Inbred Strains | 2 | 0.0 |
Cytotoxicity, Immunologic | 2 | 0.0 |
Molecular Weight | 6 | 0.0 |
Electrophoresis | 2 | 0.0 |
Cell Division | 4 | 0.0 |
Cell Survival | 2 | 0.0 |
*Chromosomes, Human, Pair 11 | 3 | 0.0 |
Mathematics | 5 | 2.0 |
Recombination, Genetic | 2 | 0.0 |
Chromatography, Gel | 4 | 0.0 |
Cochlear Microphonic Potentials/*physiology | 2 | 100.0 |
Chromatography, Affinity | 3 | 0.0 |
Chromatography, Thin Layer | 2 | 1.0 |
Perceptual Masking/*physiology | 2 | 50.0 |
Tomography, X-Ray Computed | 2 | 0.0 |
Treatment Outcome | 2 | 0.0 |
*Psychoacoustics | 5 | 100.0 |
Adaptation, Physiological | 2 | 2.0 |
Protein Folding | 2 | 0.0 |
Gene Frequency | 2 | 0.0 |
Hydrogen-Ion Concentration | 3 | 0.0 |
*Sewage | 3 | 75.0 |
Amino Acids/analysis | 3 | 1.0 |
Lymphocyte Activation | 2 | 0.0 |
*Disinfectants | 2 | 100.0 |
*Water Microbiology | 3 | 23.0 |
*Auditory Perception | 2 | 40.0 |
*Enterovirus | 2 | 100.0 |
*Plants, Medicinal | 2 | 2.0 |
Basilar Membrane/physiology | 3 | 100.0 |
Cats | 2 | 0.0 |
*Pitch Perception | 2 | 100.0 |
Muscle Contraction/*drug effects | 2 | 8.0 |
Blood Proteins | 2 | 7.0 |